ARCHIVES

STI-571 Effects Are Lasting Against GI Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

NCI to Expand Quality of Care Research, Lead HHS Panel On Cancer Care Policy.

October 1, 1999

Obey Again – Now He’s Blasting NCI For Not Helping NIOSH

September 17, 1976

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

February 7, 1992

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011